Literature DB >> 3365892

GUEPAR unicompartmental Lotus prosthesis for single-compartment femorotibial arthrosis. A five- to nine-year follow-up study.

P Hernigou1, D Goutallier.   

Abstract

The results of 52 Groupe d'utilisation et d'expérimentation des prosthèses articulaires (GUEPAR) unicompartmental Lotus knee prostheses implanted for osteoarthritis of the knee are analyzed with a follow-up time exceeding five years (five to nine years). Thirty-five knees had no weight-bearing pain, six knees had slight pain, three knees had moderate pain, and eight knees had revisions. Except for one complication from infection, all the poor results (eight revisions and three knees with moderate pain) in terms of pain can be explained by mechanical causes, i.e., femorotibial subluxation, loosening of the tibial component, or narrowing of the nonprosthetic femorotibial space. Because the cause of these poor results appears to be due to malposition of the prosthesis component, or to components that are too thick with an inadequate mechanical axis, the precision of the surgical procedure is important.

Entities:  

Mesh:

Year:  1988        PMID: 3365892

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


  3 in total

1.  Posteromedial compartment cement extrusion after unicompartmental knee arthroplasty treated by arthroscopy: a case report.

Authors:  Weon Yoo Kim; Mohamed Shafi; Young Yul Kim; Jin Young Kim; Yun Kyoung Cho; Chang Whan Han
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2005-05-05       Impact factor: 4.342

2.  [The causes of failures in unicondylar knee arthroplasties].

Authors:  B Maudhuit
Journal:  Eur J Orthop Surg Traumatol       Date:  1995-12

Review 3.  Reliability and validity of clinical outcome measurements of osteoarthritis of the hip and knee--a review of the literature.

Authors:  Y Sun; T Stürmer; K P Günther; H Brenner
Journal:  Clin Rheumatol       Date:  1997-03       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.